Insider · CIK 0002004979
Roopal Thakkar
officer
Files at ABBV (AbbVie Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | ABBV AbbVie Inc. | FTax withholding Common Stock, $0.01 par value | -4,678 | $205.02 | $959k | 42,276 | Mar 4, 2025 |
| Feb 13, 2025 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +3,595 | $0.00 | $0 | 39,994 | Feb 18, 2025 |
| Feb 13, 2025 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +1,474 | $0.00 | $0 | 41,468 | Feb 18, 2025 |
| Feb 13, 2025 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +2,138 | $0.00 | $0 | 43,606 | Feb 18, 2025 |
| Feb 13, 2025 | ABBV AbbVie Inc. | AGrant or award Common Stock, $0.01 par value | +3,348 | $0.00 | $0 | 46,954 | Feb 18, 2025 |
| Feb 13, 2025 | ABBV AbbVie Inc. | AGrant or award Option (Right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Feb 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.